Bridgewater Associates’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-11,871
Closed -$142K 771
2023
Q2
$142K Sell
11,871
-106,374
-90% -$1.45M ﹤0.01% 693
2023
Q1
$1.54M Sell
118,245
-55,352
-32% -$907K 0.01% 503
2022
Q4
$2.57M Sell
173,597
-159,372
-48% -$1.74M 0.01% 489
2022
Q3
$2.95M Buy
332,969
+17,007
+5% +$214K 0.01% 481
2022
Q2
$3.99M Sell
315,962
-2,272
-0.7% -$28.9K 0.02% 546
2022
Q1
$6.02M Buy
318,234
+105,134
+49% +$2.68M 0.02% 415
2021
Q4
$7.48M Buy
213,100
+42,549
+25% +$1.38M 0.04% 227
2021
Q3
$6.24M Buy
170,551
+81,634
+92% +$3.21M 0.03% 263
2021
Q2
$3.49M Sell
88,917
-2,444
-3% -$70.6K 0.02% 399
2021
Q1
$2.58M Sell
91,361
-29,548
-24% -$942K 0.02% 263
2020
Q4
$3.87M Buy
120,909
+10,004
+9% +$308K 0.03% 222
2020
Q3
$3.58M Buy
110,905
+36,259
+49% +$1.13M 0.04% 175
2020
Q2
$2.06M Buy
74,646
+58,513
+363% +$1.27M 0.03% 100
2020
Q1
$288K Sell
16,133
-689
-4% -$16.6K 0.01% 346
2019
Q4
$422K Buy
16,822
+324
+2% +$7.09K ﹤0.01% 433
2019
Q3
$294K Buy
16,498
+1,569
+11% +$32.7K ﹤0.01% 308
2019
Q2
$328K Buy
+14,929
New +$426K ﹤0.01% 289

Other funds holding HCM

Bridgewater Associates's HCM Position: Q3 2023 in Review

Bridgewater Associates sold out of HUTCHMED (HCM) in Q3 2023, closing a stake of 11,871 shares — an estimated $142K sold.

Bridgewater Associates first reported a position in HCM in Q2 2019 and held it in 17 quarters. The position peaked at $7.48M in Q4 2021. 65 funds tracked by Wall St. Rank hold HCM as of Q3 2023.

  • Bridgewater Associates reported no remaining HUTCHMED position as of Q3 2023 after selling out during the quarter.
  • Bridgewater Associates sold 11,871 HUTCHMED shares in Q3 2023, an estimated $142K.
  • Bridgewater Associates first reported a position in HUTCHMED in Q2 2019 and held it in 17 quarters.
  • Bridgewater Associates's HUTCHMED position peaked at $7.48M in Q4 2021.
  • 65 funds tracked by Wall St. Rank held HUTCHMED as of Q3 2023.

Based on Bridgewater Associates's 13F filing for Q3 2023, filed 13 Nov 2023.